A Study of RVT-1201 in Patients With Pulmonary Arterial Hypertension (ELEVATE 1)

Condition:   Pulmonary Arterial Hypertension Interventions:   Drug: RVT-1201;   Drug: Placebo Sponsors:   Altavant Sciences GmbH;   Altavant Sciences, Inc.;   PPD Not yet recruiting

Source: ClinicalTrials.gov - April 23, 2019 Category: Research Source Type: clinical trials